High Net Worth Advisory Group’s Molecular Partners MOLN Stock Holding History

High Net Worth Advisory Group’s Portfolio MOLN Stock Details MOLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,000	Closed	-$7K	–	707
2022 Q2	$7K	Buy	+1,000	New	+$10.3K	﹤0.01%	557

Other funds holding MOLN

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

AlphaCentric Advisors San Juan, Puerto Rico $118M AUM

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

High Net Worth Advisory Group's MOLN Position: Q3 2022 in Review

High Net Worth Advisory Group sold out of Molecular Partners (MOLN) in Q3 2022, closing a stake of 1,000 shares — an estimated $7K sold.

High Net Worth Advisory Group first reported a position in MOLN in Q2 2022 and held it in 1 quarter. The position peaked at $7K in Q2 2022. 8 funds tracked by Wall St. Rank hold MOLN as of Q3 2022.

High Net Worth Advisory Group reported no remaining Molecular Partners position as of Q3 2022 after selling out during the quarter.
High Net Worth Advisory Group sold 1,000 Molecular Partners shares in Q3 2022, an estimated $7K.
High Net Worth Advisory Group first reported a position in Molecular Partners in Q2 2022 and held it in 1 quarter.
High Net Worth Advisory Group's Molecular Partners position peaked at $7K in Q2 2022.
8 funds tracked by Wall St. Rank held Molecular Partners as of Q3 2022.

Based on High Net Worth Advisory Group's 13F filing for Q3 2022, filed 24 Oct 2022.